Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells

Nutrition and Cancer

Volumn 63, Issue 3, 2011, Pages 456-465

  Parasramka, Mansi A ^a   Gupta, Smiti V ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMETASTATIC AGENT; CASPASE 3; CASPASE 9; GARCINOL; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; K RAS PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PHENOTYPE; PROTEIN EXPRESSION; WOUND HEALING;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DINOPROSTONE; GENES, RAS; HUMANS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; TERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

AGOUTI PACA; GARCINIA INDICA;

EID: 79957540534     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.535962     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al.: Cancer statistics, 2009. CA Cancer J Clin 59, 225-249, 2009.
2. Ito C, Itoigawa M, Miyamoto Y, Onoda S, Rao KS, et al.: Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities. J Nat Prod 66, 206-209, 2003. (Pubitemid 36278230)
3. Ohnishi H, Asamoto M, Tujimura K, Hokaiwado N, Takahashi S, et al.: Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci 95, 936-942, 2004. (Pubitemid 40089584)
4. Hokaiwado N, Asamoto M, Tsujimura K, Hirota T, Ichihara T, et al.: Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system. Cancer Sci 95, 123-130, 2004. (Pubitemid 38404312)
5. Tanaka T, Kohno H, Shimada R, Kagami S, Yamaguchi F, et al.: Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21, 1183-1189, 2000. (Pubitemid 30389345)
6. Yoshida K, Tanaka T, Hirose Y, Yamaguchi F, Kohno H, et al.: Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Cancer Lett 221, 29-39, 2005. (Pubitemid 40387906)
7. Hong J, Kwon SJ, Sang S, Ju J, Zhou JN, et al.: Effects of garcinol and its derivatives on intestinal cell growth: inhibitory effects and autoxidation-dependent growth-stimulatory effects. Free Radic Biol Med 42, 1211-1221, 2007. (Pubitemid 46428513)
8. Rukachaisirikul V, Naklue W, Sukpondma Y, and Phongpaichit S: An antibacterial biphenyl derivative from Garcinia bancana MIQ. Chem Pharm Bull (Tokyo) 53, 342-343, 2005. (Pubitemid 40879912)
9. Iinuma M, Tosa H, Tanaka T, Kanamaru S, Asai F, et al.: Antibacterial activity of some Garcinia benzophenone derivatives against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 19, 311-314, 1996. (Pubitemid 26088607)
10. Yamaguchi F, Ariga T, Yoshimura Y, and Nakazawa H: Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 48, 180-185, 2000. (Pubitemid 30120339)
11. Yamaguchi F, Saito M, Ariga T, Yoshimura Y, and Nakazawa H: Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 48, 2320-2325, 2000. (Pubitemid 30431234)
12. Matsumoto K, Akao Y, Kobayashi E, Ito T, Ohguchi K, et al.: Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull 26, 569-571, 2003.
13. Pan MH, Chang WL, Lin-Shiau SY, Ho CT, and Lin JK: Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 49, 1464-1474, 2001.
14. Liao CH, Sang S, Ho CT, and Lin JK: Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through downregulation of Src, ERK, and Akt survival signaling in human colon cancer cells. J Cell Biochem 96, 155-169, 2005. (Pubitemid 41420111)
15. Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, et al.: Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279, 33716-33726, 2004. (Pubitemid 39063021)
16. Liao CH, Sang S, Liang YC, Ho CT, and Lin JK: Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by Garcinol. Mol Carcinog 41, 140-149, 2004. (Pubitemid 39435111)
17. Hong J, Sang S, Park HJ, Kwon SJ, Suh N, et al.: Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives. Carcinogenesis 27, 278-286, 2006. (Pubitemid 43159880)
18. Chaturvedi MM, Mukhopadhyay A, and Aggarwal BB: Assay for redox-sensitive transcription factor. Methods Enzymol 319, 585-602, 2000. (Pubitemid 30448077)
19. Chinni SR, Li Y, Upadhyay S, Koppolu PK, and Sarkar FH: Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20, 2927-2936, 2001.
20. Gasparini G, Longo R, Sarmiento R, and Morabito A: Inhibitors of cyclooxygenase 2: a new class of anticancer agents? Lancet Oncol 4, 605-615, 2003.
21. Bergmann F, Breinig M, Hopfner M, Rieker RJ, Fischer L, et al.: Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors? Am J Gastroenterol 104, 171-181, 2009.
22. Sarkar FH, Adsule S, Li Y, and Padhye S: Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 7, 599-608, 2007. (Pubitemid 47099180)
23. Koeberle A, Northoff H, and Werz O: Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol. Biochem Pharmacol 77, 1513-1521, 2009.
24. Crane CH, Mason K, Janjan NA, and Milas L: Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer. Am J Clin Oncol 26, S81-S84, 2003. (Pubitemid 36961146)
25. Sebens S, Arlt A, and Schafer H: NF-kappaB as a molecular target in the therapy of pancreatic carcinoma. Recent Results Cancer Res 177, 151-164; 2008.
26. Melisi D and Chiao PJ: NF-kappa B as a target for cancer therapy. Expert Opin Ther Targets 11, 133-144, 2007.
27. Nakanishi C and Toi M: Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5, 297-309, 2005. (Pubitemid 40488635)
28. Sarkar FH, Li Y, Wang Z, and Kong D: NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 27, 293-319, 2008.
29. Das KC and White CW: Activation of NF-kappaB by antineoplastic agents: role of protein kinase C. J Biol Chem 272, 14914-14920, 1997. (Pubitemid 27251763)
30. Kuwada Y, Sasaki T, Morinaka K, Kitadai Y, Mukaida N, et al.: Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int J Oncol 22, 765-771, 2003.
31. Shi Q, Le X, Wang B, Xiong Q, Abbruzzese JL, et al.: Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells. J Interferon Cytokine Res 20, 1023-1028, 2000.
32. Shi Q, Le X, Abbruzzese JL, Wang B, Mujaida N, et al.: Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J Interferon Cytokine Res 19, 1363-1371, 1999. (Pubitemid 30032938)